tiprankstipranks
Advertisement

NUMG - ETF AI Analysis

Compare

Top Page

NUMG

Nuveen ESG Mid-Cap Growth ETF (NUMG)

Rating:69Neutral
Price Target:
NUMG, the Nuveen ESG Mid-Cap Growth ETF, has a solid overall rating driven by strong, growing companies like Comfort Systems USA and Quanta Services, which show robust revenue growth, healthy cash flow, and positive earnings trends. Holdings such as Axon and Verisk Analytics add growth potential but also introduce risks like bearish technical signals, high valuations, and higher leverage, making valuation and volatility key risk factors for the fund.
Positive Factors
Strong Top Holdings Performance
Most of the largest positions have shown strong gains this year, which has helped support the fund despite recent weakness.
Sector Diversification Across Growth Areas
The ETF spreads its investments across technology, industrials, health care, consumer cyclical, and other sectors, reducing reliance on any single industry.
Moderate Expense Ratio
The fund’s fee level is reasonable for an actively screened ESG mid-cap growth strategy, allowing investors to keep more of their returns compared with higher-cost funds.
Negative Factors
Recent Weak Overall Performance
The ETF has delivered weak returns over the past month, three months, and year to date, which may concern investors looking for near-term momentum.
Single-Stock Risk in Top Holdings
A meaningful portion of the portfolio is concentrated in a handful of names, so a downturn in one or two key holdings could noticeably hurt results.
Heavy U.S.-Only Exposure
With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is highly tied to the U.S. market’s fortunes.

NUMG vs. SPDR S&P 500 ETF (SPY)

NUMG Summary

Nuveen ESG Mid-Cap Growth ETF (NUMG) tracks the MSCI Nuveen ESG USA Mid Cap Growth Index, focusing on medium‑sized U.S. companies that are growing quickly and meet environmental, social, and governance (ESG) standards. It holds businesses like Ulta Beauty and Carvana, along with many tech, industrial, and health care names, giving investors a diversified way to seek long‑term growth while supporting more responsible corporate practices. This fund can be attractive for investors who want growth plus an ESG tilt, but its share price can rise and fall sharply with the stock market and mid‑cap growth stocks in particular.
How much will it cost me?The Nuveen ESG Mid-Cap Growth ETF (NUMG) has an expense ratio of 0.31%, which means you’ll pay $3.10 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on selecting mid-cap growth companies that meet strict ESG criteria.
What would affect this ETF?The Nuveen ESG Mid-Cap Growth ETF (NUMG) could benefit from increased interest in ESG investing and the growth potential of mid-cap companies, particularly in sectors like Technology and Health Care, which are known for innovation. However, it may face challenges from economic downturns, rising interest rates that could impact growth stocks, or regulatory changes affecting ESG criteria. Its focus on U.S. mid-cap stocks also makes it sensitive to domestic economic conditions and sector-specific trends.

NUMG Top 10 Holdings

NUMG is leaning hard into U.S. mid-cap growth, with a clear tilt toward technology and industrial names. Quanta Services and Ciena are the current engines, rising on strong growth and upbeat outlooks. Comfort Systems is still helping over the longer run, even if it’s recently hit a speed bump. On the other side, Idexx Laboratories and Carvana are losing steam, dragging on returns, while Axon and Datadog show mixed signals. Overall, the fund’s story is one of concentrated, U.S.-focused growth with a few high-flyers offset by notable laggards.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Quanta Services6.27%$20.59M$87.58B117.22%
78
Outperform
Ciena6.01%$19.74M$70.14B720.34%
70
Outperform
Comfort Systems4.67%$15.32M$56.03B362.97%
80
Outperform
WW Grainger4.28%$14.05M$55.47B16.14%
73
Outperform
Carvana Co3.76%$12.34M$73.69B75.48%
66
Neutral
Idexx Laboratories3.66%$12.02M$44.72B41.85%
78
Outperform
Alnylam Pharma3.62%$11.89M$42.72B38.74%
60
Neutral
EMCOR Group3.31%$10.86M$35.73B110.53%
73
Outperform
Interactive Brokers3.03%$9.95M$31.73B72.38%
75
Outperform
Datadog2.93%$9.62M$37.17B19.81%
69
Neutral

NUMG Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
42.72
Negative
100DMA
45.17
Negative
200DMA
46.80
Negative
Market Momentum
MACD
-0.40
Negative
RSI
50.45
Neutral
STOCH
60.09
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NUMG, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 41.53, equal to the 50-day MA of 42.72, and equal to the 200-day MA of 46.80, indicating a neutral trend. The MACD of -0.40 indicates Negative momentum. The RSI at 50.45 is Neutral, neither overbought nor oversold. The STOCH value of 60.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NUMG.

NUMG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$332.27M0.31%
69
Neutral
$489.22M0.73%
70
Neutral
$322.92M0.35%
73
Outperform
$154.60M0.80%
74
Outperform
$122.37M0.60%
59
Neutral
$118.21M0.85%
69
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NUMG
Nuveen ESG Mid-Cap Growth ETF
42.06
1.68
4.16%
FNY
First Trust Mid Cap Growth AlphaDEX Fund
RFG
Invesco S&P Midcap 400 Pure Growth ETF
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
FRTY
Alger Mid Cap 40 ETF
TMFM
Motley Fool Mid-Cap Growth ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement